Ninety One (UK)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149M Sell
3,501,985
-3,806,555
-52% -$207M 0.33% 64
2026
Q1
$459M Buy
7,308,540
+1,863,991
+34% +$149M 1.06% 28
2025
Q4
$519M Buy
5,444,549
+81,023
+2% +$7.94M 1.11% 26
2025
Q3
$524M Buy
5,363,526
+217,308
+4% +$22.5M 1.13% 25
2025
Q2
$553M Buy
5,146,218
+1,290,414
+33% +$131M 1.3% 21
2025
Q1
$389M Buy
3,855,804
+232,997
+6% +$23.5M 1.08% 27
2024
Q4
$324M Sell
3,622,807
-591,945
-14% -$52.1M 0.87% 30
2024
Q3
$353M Sell
4,214,752
-98,335
-2% -$7.75M 0.94% 28
2024
Q2
$332M Sell
4,313,087
-86,013
-2% -$6.3M 0.92% 29
2024
Q1
$301M Sell
4,399,100
-49,676
-1% -$3.19M 0.85% 37
2023
Q4
$257M Sell
4,448,776
-412,050
-8% -$22M 0.77% 40
2023
Q3
$257M Sell
4,860,826
-170,404
-3% -$8.94M 0.81% 38
2023
Q2
$272M Sell
5,031,230
-24,490
-0.5% -$1.28M 0.79% 40
2023
Q1
$253M Sell
5,055,720
-703,327
-12% -$33.1M 0.79% 40
2022
Q4
$266M Buy
5,759,047
+258,813
+5% +$11.2M 0.85% 37
2022
Q3
$213M Sell
5,500,234
-726,848
-12% -$29.2M 0.7% 42
2022
Q2
$232M Buy
+6,227,082
New +$253M 0.69% 47

Other funds holding BSX

Ninety One (UK)'s BSX Position: Q2 2026 in Review

Ninety One (UK) reduced its Boston Scientific (BSX) stake by 52% in Q2 2026, selling an estimated $207M and leaving 3,501,985 shares worth $149M. The position accounts for 0.33% of the portfolio, ranked #64.

Ninety One (UK) first reported a position in BSX in Q2 2022 and has held it in 17 quarters since. The position peaked at $553M in Q2 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ninety One (UK) held 3,501,985 shares of Boston Scientific worth $149M as of Q2 2026.
  • Ninety One (UK) sold 3,806,555 Boston Scientific shares in Q2 2026, an estimated $207M.
  • Boston Scientific made up 0.33% of Ninety One (UK)'s portfolio in Q2 2026, its #64 holding.
  • Ninety One (UK) first reported a position in Boston Scientific in Q2 2022 and has held it in 17 quarters since.
  • Ninety One (UK)'s Boston Scientific position peaked at $553M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.